Gotowa bibliografia na temat „Platelet factor 4”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Spis treści
Zobacz listy aktualnych artykułów, książek, rozpraw, streszczeń i innych źródeł naukowych na temat „Platelet factor 4”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Artykuły w czasopismach na temat "Platelet factor 4"
Shimizu, T., Y. Ishikawa, Y. Morishima, T. Fukuda i K. Kato. "Platelet factor 4 release from the platelets stored in platelet concentrates". Transfusion 25, nr 5 (wrzesień 1985): 420–23. http://dx.doi.org/10.1046/j.1537-2995.1985.25586020114.x.
Pełny tekst źródłaCAPITANIO, A., S. NIEWIAROWSKI, B. RUCINSKI, G. TUSZYNSKI, C. CIERNIEWSKI, D. HERSHOCK i E. KORNECKI. "Interaction of platelet factor 4 with human platelets". Biochimica et Biophysica Acta (BBA) - General Subjects 839, nr 2 (17.04.1985): 161–73. http://dx.doi.org/10.1016/0304-4165(85)90033-9.
Pełny tekst źródłaO'Brien, J. R. "PLATELET FACTOR 4 (PF 4) AND THE PLATELET MEMBRANE". Acta Medica Scandinavica 191, S525 (24.04.2009): 65–66. http://dx.doi.org/10.1111/j.0954-6820.1972.tb05793.x.
Pełny tekst źródłaSottile, Jane, Deane F. Mosher, Jan Fullenweider i James N. George. "Human Platelets Contain mRNA Transcripts for Platelet Factor 4 and Actin". Thrombosis and Haemostasis 62, nr 04 (1989): 1100–1102. http://dx.doi.org/10.1055/s-0038-1647125.
Pełny tekst źródłaCowan, S. W., E. N. Bakshi, K. J. Machin i N. W. Isaacs. "Binding of heparin to human platelet factor 4". Biochemical Journal 234, nr 2 (1.03.1986): 485–88. http://dx.doi.org/10.1042/bj2340485.
Pełny tekst źródłaDickhout, Annemiek, Bibian M. E. Tullemans, Johan W. M. Heemskerk, Victor L. J. L. Thijssen, Marijke J. E. Kuijpers i Rory R. Koenen. "Galectin-1 and platelet factor 4 (CXCL4) induce complementary platelet responses in vitro". PLOS ONE 16, nr 1 (7.01.2021): e0244736. http://dx.doi.org/10.1371/journal.pone.0244736.
Pełny tekst źródłaDay, H. James, H. Stormorken i H. Holmsen. "Subcellular Localization of Platelet Factor 3 and Platelet Factor 4". Scandinavian Journal of Haematology 10, nr 4 (24.04.2009): 254–60. http://dx.doi.org/10.1111/j.1600-0609.1973.tb00069.x.
Pełny tekst źródłaLeavitt, Andrew D. "What for platelet factor 4?" Blood 110, nr 4 (15.08.2007): 1090. http://dx.doi.org/10.1182/blood-2007-05-091363.
Pełny tekst źródłaRobinson, C. "Recombinant Human Platelet Factor 4". Drugs of the Future 20, nr 2 (1995): 148. http://dx.doi.org/10.1358/dof.1995.020.02.284334.
Pełny tekst źródłaLorenz, R., i M. Brauer. "Platelet factor 4 (PF 4) in septicaemia". Infection 16, nr 5 (wrzesień 1988): 273–76. http://dx.doi.org/10.1007/bf01645070.
Pełny tekst źródłaRozprawy doktorskie na temat "Platelet factor 4"
Brousseau-Nault, Mathieu. "Chronic periodontitis is associated with platelet factor 4 (PF4) secretion". Thesis, University of British Columbia, 2016. http://hdl.handle.net/2429/59016.
Pełny tekst źródłaDentistry, Faculty of
Graduate
Javaid, Mohammad. "Platelet factor 4 upregulates matrix metalloproteinase-1 production in gingival fibroblasts". Thesis, University of British Columbia, 2016. http://hdl.handle.net/2429/60244.
Pełny tekst źródłaDentistry, Faculty of
Graduate
Kreimann, Martin [Verfasser]. "Characterization of complexes between platelet factor 4 and heparin / Martin Kreimann". Greifswald : Universitätsbibliothek Greifswald, 2015. http://d-nb.info/1065685513/34.
Pełny tekst źródłaYasuba, Hirotaka. "INCREASED RELEASABILITY OF PLATELET PRODUCTS AND REDUCED HEPARIN-INDUCED PLATELET FACTOR 4 RELEASE FROM ENDOTHELIAL CELLS IN BRONCHIAL ASTHMA". Kyoto University, 1991. http://hdl.handle.net/2433/168713.
Pełny tekst źródłaKyoto University (京都大学)
0048
新制・課程博士
医学博士
甲第4772号
医博第1273号
新制||医||500(附属図書館)
UT51-91-E143
京都大学大学院医学研究科内科系専攻
(主査)教授 三河 春樹, 教授 泉 孝英, 教授 大島 駿作
学位規則第5条第1項該当
Rudmann, Sally V. "The effect of twenty minutes of aerobic exercise on in vivo platelet release in moderately trained females : radioimmunoassay of platelet factor 4 beta-thromboglobulin /". The Ohio State University, 1986. http://rave.ohiolink.edu/etdc/view?acc_num=osu1487266362337217.
Pełny tekst źródłaCharpin, Jean-Marie. "Physiopathologie de la bronchiolite obliterante chez les transplantes pulmonaires : implication de 4 mediateurs profibrosants : tgf-beta, igf-1,et-1 et pdgf". Paris 5, 2000. http://www.theses.fr/2000PA05N104.
Pełny tekst źródłaEtherington, Michael Denis. "An investigation into the measurement of plasma intraplatelet platelet factor 4 and beta-thromboglobulin in health and thrombotic disease". Thesis, University of Southampton, 1988. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.278486.
Pełny tekst źródłaKimmerle, Sabine. "Rapid determination of Anti-Heparin/Platelet factor 4 antibody titers in the diagnosis of Heparin-induced Thrombocytopenia$cSabine Kimmerle". Bern : [s.n.], 2003. http://www.stub.unibe.ch/html/haupt/datenbanken/diss/bestell.html.
Pełny tekst źródłaNewman, Peter Michael Pathology UNSW. "Antibody and Antigen in Heparin-Induced Thrombocytopenia". Awarded by:University of New South Wales. Pathology, 2000. http://handle.unsw.edu.au/1959.4/17485.
Pełny tekst źródłaLibraire, Julie. "Le facteur 4 plaquettaire (PF4/CXCL4) prévient la formation du complexe initial de l’inhibiteur de l’activateur du plasminogène (PAI-1) avec sa cible d’origine tissulaire (t-PA)". Thesis, Paris 5, 2012. http://www.theses.fr/2012PA05P654.
Pełny tekst źródłaPlatelet factor 4 (PF4/CXCL4) is a tetramer constituted of four identical 7,8 kDa subunits released in large quantities by platelets during primary heamostasis (allowing initial clogging of a vascular injury). Study of fibrin clot formation in the presence of PF4 shows an increase of the final clot turbidity: PF4 modifies the formed network. Given that most fibrinolysis actors are bound to the fibrin clot and that PF4 modifies its structure we thought it would be interesting to investigate if PF4 also influences fibrinolysis. Clot lysis is performed by plasmin originating from activation of its precursor by tissue plasminogen activator (t-PA) with fibrin itself as cofactor of the reaction. We have studied lysis of plasma clots formed by activation of the coagulation cascade in static condition and in a Chandler loop model mimicking arterial thrombosis. Half-times of lysis decreased in the presence of PF4 in both systems. However, PF4 had no longer detectable influence on the half-time of lysis with clots formed by direct addition of thrombin on purified fibrinogen. Observation suggested that the observed decrease of the half-time of lysis induced by PF4 did not originate from its influence on fibrin clot formation and that PF4 had little effect if any on plasminogen activation or plasmin activity. We confirmed this hypothesis by comparing amydolytic activities of t-PA and plasmin (added or generated through plasminogen activation). In purified system, fibrinolysis inhibitors are absent. The two main inhibitors are plasminogen activator inhibitor-1 (PAI-1) and α2-antiplasmin (α2-AP). Lysis of clots obtained from α2-AP deficient plasma showed a decrease of the half-time of lysis in the presence of PF4 (as in normal plasma), whereas in PAI-1 deficient plasma half-time of lysis was unchanged. Moreover if PAI-1 was added to the purified system, half-time of lysis decreased in the presence of PF4. Observations therefore suggested that PF4 prevented directly or indirectly t-PA inhibition by PAI-1. Kinetics of the amidolytic activity of t-PA inhibition by PAI-1 in the presence or not of PF4, determination of its stoichiometry and Western blot analysis of these inhibition kinetics revealed that PF4 is a fibrinolysis modulator which delays formation of the initial (Michaelis) complex between t-PA and PAI-1. This new feature of PF4 is consistent and complementary with its recently described role as a modulator of TAFI activation
Książki na temat "Platelet factor 4"
Hsiung, Marilyn S. Mechanisms of D(4) dopamine receptor-mediated platelet-derived growth factor receptor-beta transactivation. 2006.
Znajdź pełny tekst źródłaCurry, Nicola, i Raza Alikhan. Normal platelet function. Redaktorzy Patrick Davey i David Sprigings. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780199568741.003.0281.
Pełny tekst źródłaMacdougall, Iain C. Clinical aspects and overview of renal anaemia. Redaktor David J. Goldsmith. Oxford University Press, 2015. http://dx.doi.org/10.1093/med/9780199592548.003.0123.
Pełny tekst źródłaCzęści książek na temat "Platelet factor 4"
Pepper, D. S., i C. V. Prowse. "Beta-thromboglobulin and platelet factor 4". W ECAT Assay Procedures A Manual of Laboratory Techniques, 21–34. Dordrecht: Springer Netherlands, 1992. http://dx.doi.org/10.1007/978-94-011-2992-3_3.
Pełny tekst źródłaIshii, Satoshi. "Platelet-Activating Factor (PAF) in Infectious Diseases". W Bioactive Lipid Mediators, 95–108. Tokyo: Springer Japan, 2015. http://dx.doi.org/10.1007/978-4-431-55669-5_7.
Pełny tekst źródłaTerashita, Z., M. Kawamura, Y. Imura i K. Nishikawa. "Possible Involvement of Platelet Activating Factor (PAF) in Tissue Factor Generation and the Pathogenesis of Disseminated Intravascular Coagulation (DIC)". W Current Aspects of Blood Coagulation, Fibrinolysis, and Platelets, 58–63. Tokyo: Springer Japan, 1993. http://dx.doi.org/10.1007/978-4-431-68323-0_10.
Pełny tekst źródłaBraquet, Pierre G. "Platelet-Activating Factor and Its Antagonists: Scientific Background and Clinical Applications of Ginkgolides". W Ginkgo Biloba A Global Treasure, 359–69. Tokyo: Springer Japan, 1997. http://dx.doi.org/10.1007/978-4-431-68416-9_27.
Pełny tekst źródłaHirashima, Yutaka, Ryoko Kato, Tomoaki Ohmori, Takeshi Nagahori, Michiharu Nishijima, Shunro Endo, Akira Takaku i Ken Karasawa. "The Role of Platelet-Activating Factor (PAF) in the Development of Chronic Subdural Hematoma". W Recent Advances in Neurotraumatology, 61–64. Tokyo: Springer Japan, 1993. http://dx.doi.org/10.1007/978-4-431-68231-8_10.
Pełny tekst źródłaAbe, Mamoru, Masaharu Matsuzaki, Takashi Inoue, Hirotoshi Sano i Tetsuo Kanno. "Significance of Platelet-Activating Factor (PAF) and PAF — Acethylhydrolase in the Pathogenesis of Chronic Subdural Hematoma". W Recent Advances in Neurotraumatology, 65–68. Tokyo: Springer Japan, 1993. http://dx.doi.org/10.1007/978-4-431-68231-8_11.
Pełny tekst źródłaMiyazaki, Kohji, Kohji Fukunaga, Iqbal Munir, Hitoshi Okamura i Eishichi Miyamoto. "Expression of Cyclooxygenase (COX)-2 in Human Endometrial Adenocarcinoma Cell Line HEC-1B: An In Vitro Model of the Expression of COX-2 by Platelet-Activating Factor, Human Chorionic Gonadotropin and Prostaglandin E2, and the Possible Signaling Pathways Involved". W Cell and Molecular Biology of Endometrial Carcinoma, 123–38. Tokyo: Springer Japan, 2003. http://dx.doi.org/10.1007/978-4-431-53981-0_8.
Pełny tekst źródłaMorita, Takashi, i Hideko Atoda. "The Structural Characterization of Coagulation Factor IX/Factor X-Binding Protein Isolated from the Venom of Trimeresurus Flavoviridis". W Current Aspects of Blood Coagulation, Fibrinolysis, and Platelets, 35–40. Tokyo: Springer Japan, 1993. http://dx.doi.org/10.1007/978-4-431-68323-0_6.
Pełny tekst źródłaShen, Ming-Ching, Shu-Wha Lin, Pei-Chu Yang i Chin-Chin Huang. "Studies of Factor VIII Inhibitors in Chinese Hemophilia a Patients". W Current Aspects of Blood Coagulation, Fibrinolysis, and Platelets, 49–54. Tokyo: Springer Japan, 1993. http://dx.doi.org/10.1007/978-4-431-68323-0_8.
Pełny tekst źródłaVanhoutte, P. M. "Endothelium-Derived Vasoactive Factors, Platelets and Coronary Disease". W Coronary Circulation in Physiological and Pathophysiological States, 89–102. Tokyo: Springer Japan, 1991. http://dx.doi.org/10.1007/978-4-431-68108-3_6.
Pełny tekst źródłaStreszczenia konferencji na temat "Platelet factor 4"
Bryckaert, M. C., A. Wasteson, G. Tobelem, F. Rendu i J. P. Caen. "PLATELET DERIVED GROWTH FACTOR (PDGF) BINDS TO HUMAN PLATELETS AND MODULATES PLATELET ACTIVATION". W XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1643493.
Pełny tekst źródłaOrdinas, A., E. Bastida, M. Garrido, J. Monteagudo, L. de Marco i R. Castillo. "ASIALO VON WILLEBRAND FACTOR ENHANCES PLATELET ADHESION TO VASCULAR SUBENDOTHELIUM". W XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1644098.
Pełny tekst źródłaBoschetti, C., A. Vicari, E. Cofrancesco, A. Della Volpe, G. Moreo, E. Po-gliani, G. Pozza i E. Polli. "HEPARIN-RELEASED PLATELET FACTOR 4 (HR-PF4) IN DIABETIC MICR0VAS-CULAR DISEASE". W XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1643498.
Pełny tekst źródłaBodzenta-Lukaszvk, A., K. Krupiński i M. Bielawiec. "PLATELET FUNCTION AND KALLIKREIN SYSTEM IN PATIENTS WITH ESSENTIAL HYPERTENSION". W XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1644258.
Pełny tekst źródłaVigh, Zs, i I. Scharrer. "INVESTIGATIONS ON MULTIMERIC STRUCTURE OF PLATELET VON WILLE-BRAND FACTOR IN PATIENTS WITH HEREDITARY DISORDERS OF PLATELET FUNCTION". W XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1644087.
Pełny tekst źródłaGewirtz, A., W. Y. Xu, B. Rucinski i S. Niewiarowski. "SELECTIVE INHIBITION OF HUMAN MEGAKARYOCYTOPOIESIS IN VITRO BY HIGHLY PURIFIED PLATELET FACTOR 4". W XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1644621.
Pełny tekst źródłaRucinski, B., G. J. Stewart, G. Boden i S. Niewiarowski. "INTERACTION OF PLATELET FACTOR 4 WITH HEPATOCYTES AND ITS POSSIBLE SIGNIFICANCE IN HEMOSTASIS". W XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1643500.
Pełny tekst źródłaCOEFFIER, e., D. Delautier, J.-P. Le Couedic, M. Chinqnard i J. Benveniste. "ACTIVATED HUMAN PLATELETS AND NEUTROPHILS COOPERATE FOR THE FORMATION OF PAF-ACETHER (PLATELET-ACTIVATING FACTOR)". W XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1642881.
Pełny tekst źródłaSuzuki, Sozo, Kazuo Mori, Koji Sugai, Yasuyuki Akutsu, Masaaki Ishikawa, Hideaki Sakai i Katsuhide Hiwatashi. "ELECTRONMICROSCOPIC STUDIES ON PLATELETS AND MEGAKARYOCYTES IN GIANT PLATELET SYNDROME". W XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1644560.
Pełny tekst źródłaKim, Youngmi, Eunhee Kim, Olga Guryanova, Masahiro Hitomi, Andrew E. Sloan, Anita B. Hjelmeland i Jeremy N. Rich. "Abstract 5192: Platelet derived growth factor receptors differentially inform intertumoral and intratumoral heterogeneity". W Proceedings: AACR 103rd Annual Meeting 2012‐‐ Mar 31‐Apr 4, 2012; Chicago, IL. American Association for Cancer Research, 2012. http://dx.doi.org/10.1158/1538-7445.am2012-5192.
Pełny tekst źródła